POR TODOS ELLOS: Double-key chemotherapy for childhood leukemia — protecting the payload so it detonates only where it must

This preprint presents a theoretical design hypothesis for laboratory testing only. It is not a treatment, it has not been tested in humans, it received no funding, and the author declares no conflicts of interest. Patients and families should consult their treating oncologist.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23719671
Primary Topic
Acute Lymphoblastic Leukemia research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

POR TODOS ELLOS: Double-key chemotherapy for childhood leukemia — protecting the payload so it detonates only where it must

G. Javier Dinarte
Zenodo (CERN European Organization for Nuclear Research)
Acute Lymphoblastic Leukemia research
preprint

POR TODOS ELLOS: Double-key chemotherapy for childhood leukemia — protecting the payload so it detonates only where it must

G. Javier Dinarte
preprint en

Abstract

This preprint presents a theoretical design hypothesis for laboratory testing only. It is not a treatment, it has not been tested in humans, it received no funding, and the author declares no conflicts of interest. Patients and families should consult their treating oncologist.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
POR TODOS ELLOS: Double-key chemotherapy for childhood leukemia — protecting the payload so it detonates only where it must — G. Javier Dinarte · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS